FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Tuberculosis

Enabling TB Patients with Digital Adherence Technology

29 Nov 2020

Digital Adherence Technologies (DATs) are feature phone-based and smartphone-based technologies to monitor Tuberculosis (TB) medication adherence. Various DATs include:

  1. 99DOTS - a mobile call-based monitoring system
  2. Medication Event Reminder Monitor (MERM) - a visual and audio alarm-enabled digital pillbox
  3. VideoDOTS (VOT) - a mobile video-based reporting system

In 2019, the Central TB Division of India launched the Integrated Digital Adherence Technology Initiative (IDAT), the first initiative to introduce all the above three digital technologies into TB health systems. This study represents results from a mixed-methods study to assess the implementation of IDAT in eight districts across the three Indian states of Gujarat, Karnataka, and Haryana. The results and data in the study can help service providers deploy and improve IDAT services in the country.

Download PDF
PUBLISHED BY
USAID, World Health Partners
YEAR OF PUBLISHING
2019
AUTHORS
THALI

Categories

For implementers Research

RELATED
CONTENT

Innovation

Tech Innovations that could Help Us #EndTB

Technology promises to help achieve our End TB goals. How can we best deploy it?

by Rhea John 4 min read

Tuberculosis
Report For researchers

Predictive Analytics Can Help #EndTB

The document highlights how technology can be used to prevent and cure TB.

by Dr Rahul Panicker, e... 25 min read

Tuberculosis
KEY ORGANIZATIONS

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2023 Swasti Health Catalyst